Novel Agents and Combinations in Hodgkin Lymphoma

0 Views
administrator
administrator
07/09/23

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next